US Stock MarketDetailed Quotes
EFTRW EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM)
- 0.001
- 0.0000.00%
15min DelayTrading Sep 23 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.18852wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float2.490Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
About EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) Company
eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in Solana Beach, CA.
Company Profile
SymbolEFTRW
Company NameEFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM)
Listing DateMar 1, 2021
Founded2012
CEOMr. Craig R. Jalbert
MarketPink Market
Employees14
Fiscal Year Ends12-31
Address142 North Cedros Avenue,Suite B
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075
Phone1-858-925-8215
Websitehttp://www.effector.com
Company Executives
- Name
- Position
- Salary
- Craig R. Jalbert
- Chief Executive Officer, President, Director, Principal Financial Officer, Principal Accounting Officer, Treasurer and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data